Fitting my needs - HIV prevention in the age of biomedical alternatives (oral and long-acting PrEP, TasP)
Format
MODERATORS
Hanne Zimmermann
Maastricht University, Netherlands
Johann Kolstee
Maastricht University, Netherlands
Organizer
Share

The satellite focuses on the topic of biomedical HIV prevention choices that are now available: oral/long-acting PrEP and treatment as prevention (TasP). Experiences with TasP, and HIV stigma are being discussed jointly with data on user experience of oral and long-acting PrEP (e.g. SEARCH), as well as intention to use long-acting PrEP data (e.g. the European PROTECT survey w/ 20.000 participants). We will critically investigate tailored prevention potentials, unmet needs and access pathways and their impact on ending the HIV epidemic. As speakers, the following researchers covering the contexts in Europe (Kai Jonas, Johann Kolstee, Hanne Zimmermann, Haoyi Wang, The Netherlands), Southeast Asia (Natthakhet Yaemim, Thailand), Australasia (Martin Holt, Australia), Africa (Jane Kabami, Uganda), and the USA (Katie Biello) will contribute. In a panel, we are reflecting on the results with key populations represented by the following panelists Amanita Calderon-Cifuentes (Transgender Europe - TGEU), Juddy Otti (Africa Advocacy Foundation), Alex Schneider (Life4me+), Samira Hakim (Trans United Europe).

07:30
5 min
Introduction to the symposium
Maastricht University, Netherlands
07:35
20 min
Determinants of intention to use long-acting PrEP among MSM, trans* and heterosexual individuals - findings from the PROTECT survey in 20 European countries
Maastricht University, Netherlands
Maastricht University, Netherlands
Maastricht University, Netherlands
Maastricht University, Netherlands
07:55
10 min
Which method suits best? Trends in use and preferences for different HIV prevention methods among Australian gay and bisexual men and non-binary people
University of New South Wales, Australia
08:05
10 min
Randomized trial of SEARCH dynamic choice HIV prevention including injectable Cabotegravir (CAB-LA)
Infectious Diseases Research Collaboration, Uganda
08:15
10 min
Barriers and facilitators to uptake of a line-up of PrEP modalities among young sexual minority men in the United States
Brown University, United States
08:25
10 min
Interest in and intention to use long-acting PrEP among PrEP-naive MSM and MSM currently using PrEP in Thailand
PULSE Clinics, Thailand
08:35
20 min
Panel discussion with representatives of key populations
Maastricht University, Netherlands
Maastricht University, Netherlands
Transgender Europe, Germany
Trans United Europe, Netherlands
Africa Advocacy Foundation, United Kingdom
Life4me+, Switzerland
08:55
5 min
Closing remarks
Maastricht University, Netherlands